Menu Back toKEYNOTE-ADDRESS-3
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
4th DIA Cell and Gene Therapy Products Symposium in Japan
All prices are exclusive of 10% Japanese consumption tax
KEYNOTE ADDRESS 3
Daisaku Sato, PhD, MPharm, RPh
- Director, Compliance & Narcotics Division
- Ministry of Health, Labour and Welfare, Japan
Adoptive Cell Therapy with TCR-gene Engineered T Cells - Specificity, Construct and Cells -
Hiroshi Shiku, MD, PhD
- Mie University Graduate School of Medicine, Japan